These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 25818425)

  • 1. Hyaluronic acid controls the uptake pathway and intracellular trafficking of an octaarginine-modified gene vector in CD44 positive- and CD44 negative-cells.
    Yamada Y; Hashida M; Harashima H
    Biomaterials; 2015 Jun; 52():189-98. PubMed ID: 25818425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Octaarginine- and pH sensitive fusogenic peptide-modified nanoparticles for liver gene delivery.
    Khalil IA; Hayashi Y; Mizuno R; Harashima H
    J Control Release; 2011 Dec; 156(3):374-80. PubMed ID: 21864599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multifunctional envelope-type nanodevice for use in nanomedicine: concept and applications.
    Nakamura T; Akita H; Yamada Y; Hatakeyama H; Harashima H
    Acc Chem Res; 2012 Jul; 45(7):1113-21. PubMed ID: 22324902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced gene expression by a novel stearylated INF7 peptide derivative through fusion independent endosomal escape.
    El-Sayed A; Masuda T; Khalil I; Akita H; Harashima H
    J Control Release; 2009 Sep; 138(2):160-7. PubMed ID: 19465073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient short interference RNA delivery to tumor cells using a combination of octaarginine, GALA and tumor-specific, cleavable polyethylene glycol system.
    Sakurai Y; Hatakeyama H; Akita H; Oishi M; Nagasaki Y; Futaki S; Harashima H
    Biol Pharm Bull; 2009 May; 32(5):928-32. PubMed ID: 19420766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pretreatment of hepatocyte growth factor gene transfer mediated by octaarginine peptide-modified nanoparticles ameliorates LPS/D-galactosamine-induced hepatitis.
    Hayashi Y; Mizuno R; Ikramy KA; Akita H; Harashima H
    Nucleic Acid Ther; 2012 Oct; 22(5):360-3. PubMed ID: 22963044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Octaarginine-modified multifunctional envelope-type nano device for siRNA.
    Nakamura Y; Kogure K; Futaki S; Harashima H
    J Control Release; 2007 Jun; 119(3):360-7. PubMed ID: 17478000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient and High-Speed Transduction of an Antibody into Living Cells Using a Multifunctional Nanocarrier System to Control Intracellular Trafficking.
    Yamada Y; Perez SM; Tabata M; Abe J; Yasuzaki Y; Harashima H
    J Pharm Sci; 2015 Sep; 104(9):2845-54. PubMed ID: 25546552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A DNA microarray-based analysis of immune-stimulatory and transcriptional responses of dendritic cells to KALA-modified nanoparticles.
    Akita H; Ishii S; Miura N; Shaheen SM; Hayashi Y; Nakamura T; Kaji N; Baba Y; Harashima H
    Biomaterials; 2013 Nov; 34(35):8979-90. PubMed ID: 23968857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanoparticles for ex vivo siRNA delivery to dendritic cells for cancer vaccines: programmed endosomal escape and dissociation.
    Akita H; Kogure K; Moriguchi R; Nakamura Y; Higashi T; Nakamura T; Serada S; Fujimoto M; Naka T; Futaki S; Harashima H
    J Control Release; 2010 May; 143(3):311-7. PubMed ID: 20080139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KALA-modified multi-layered nanoparticles as gene carriers for MHC class-I mediated antigen presentation for a DNA vaccine.
    Shaheen SM; Akita H; Nakamura T; Takayama S; Futaki S; Yamashita A; Katoono R; Yui N; Harashima H
    Biomaterials; 2011 Sep; 32(26):6342-50. PubMed ID: 21658761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional improvement of an IRQ-PEG-MEND for delivering genes to the lung.
    Ishitsuka T; Akita H; Harashima H
    J Control Release; 2011 Aug; 154(1):77-83. PubMed ID: 21619903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An approach to transgene expression in liver endothelial cells using a liposome-based gene vector coated with hyaluronic acid.
    Yamada Y; Hashida M; Hayashi Y; Tabata M; Hyodo M; Ara MN; Ohga N; Hida K; Harashima H
    J Pharm Sci; 2013 Sep; 102(9):3119-27. PubMed ID: 23471825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Development of a novel artificial gene delivery system multifunctional envelope-type nano device for gene therapy].
    Kogure K
    Yakugaku Zasshi; 2007 Oct; 127(10):1685-91. PubMed ID: 17917425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An efficient PEGylated gene delivery system with improved targeting: Synergism between octaarginine and a fusogenic peptide.
    Khalil IA; Harashima H
    Int J Pharm; 2018 Mar; 538(1-2):179-187. PubMed ID: 29341911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reprint of: Nanoparticles for ex vivo siRNA delivery to dendritic cells for cancer vaccines: Programmed endosomal escape and dissociation.
    Akita H; Kogure K; Moriguchi R; Nakamura Y; Higashi T; Nakamura T; Serada S; Fujimoto M; Naka T; Futaki S; Harashima H
    J Control Release; 2011 Jan; 149(1):58-64. PubMed ID: 20826039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel IRQ ligand-modified nano-carrier targeted to a unique pathway of caveolar endocytic pathway.
    Mudhakir D; Akita H; Tan E; Harashima H
    J Control Release; 2008 Jan; 125(2):164-73. PubMed ID: 18054812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Development of various multifunctional envelope-type nano device MEND based on novel assembly technologies].
    Kogure K; Akita H; Harashima H
    Yakugaku Zasshi; 2008 Feb; 128(2):219-32. PubMed ID: 18239369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High density of octaarginine stimulates macropinocytosis leading to efficient intracellular trafficking for gene expression.
    Khalil IA; Kogure K; Futaki S; Harashima H
    J Biol Chem; 2006 Feb; 281(6):3544-51. PubMed ID: 16326716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficient intracellular delivery of nucleic acid pharmaceuticals using cell-penetrating peptides.
    Nakase I; Akita H; Kogure K; Gräslund A; Langel U; Harashima H; Futaki S
    Acc Chem Res; 2012 Jul; 45(7):1132-9. PubMed ID: 22208383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.